GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a "precaution", days after the U.S. Food and Drug Administration found "unacceptable" levels of probable cancer-causing impurity in the drug. | Video
Melrose Industries Plc flagged its confidence in meeting full-year forecasts on Thursday as the turnaround specialist reported a better-than-expected first-half profit, despite weakness in its automotive business.
* Shares rise as much as 3.7% to highest in almost a year
(Adds shares, analyst comments, context on performance)
Hays Plc is seeing increasing signs of weakening business confidence in Germany and Britain, the recruiter said on Thursday, sending its shares down as much as 5% despite posting higher annual net fees.
Prospects for AstraZeneca's respiratory treatments business improved on Wednesday as a three-drug inhaler was shown to ease smoker's lung and U.S. regulators granted its injectable asthma drug Fasenra special status for a rare lung condition.
G4S will look at offers for all or part of its cash transport business after its board approved hiving it off into a separate company in the first half of 2020.
Sirius Minerals Plc has suspended a planned $500 million bond sale that is central to the funding of its polyhalite mining project in northern England, sending shares in the fertiliser maker down more than 30%.
* Retail sales up ~9%, vet revenue ~19%
(Adds context on wider retail sector, analyst comments, shares)
The UK Serious Fraud Office (SFO) has opened a criminal investigation into passport and banknote printer De La Rue over "suspected corruption" in its business in South Sudan, sending its shares plunging to 16-year lows.
LONDON British fund manager Neil Woodford will keep his flagship 3.7 billion pound fund frozen for a second month running, leaving hundreds of thousands of small savers without access to their money.